Vidac Pharma Holding (STU:T9G) Other Current Liabilities : €0.21 Mil (As of Jun. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Vidac Pharma Holding Other Current Liabilities?

Vidac Pharma Holding's other current liabilities for the quarter that ended in Jun. 2024 was €0.21 Mil.

Vidac Pharma Holding's quarterly other current liabilities increased from Jun. 2023 (€0.01 Mil) to Dec. 2023 (€0.04 Mil) and increased from Dec. 2023 (€0.04 Mil) to Jun. 2024 (€0.21 Mil).

Vidac Pharma Holding's annual other current liabilities declined from Dec. 2021 (€0.04 Mil) to Dec. 2022 (€0.02 Mil) but then increased from Dec. 2022 (€0.02 Mil) to Dec. 2023 (€0.04 Mil).

Vidac Pharma Holding Other Current Liabilities Historical Data

The historical data trend for Vidac Pharma Holding's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vidac Pharma Holding Other Current Liabilities Chart

Vidac Pharma Holding Annual Data

Trend

Dec21

Dec22

Dec23

Other Current Liabilities

0.04

0.02

0.04

Vidac Pharma Holding Semi-Annual Data
	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Other Current Liabilities	Get a 7-Day Free Trial			0.10	0.02	0.01	0.04	0.21

Vidac Pharma Holding Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

Vidac Pharma Holding Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of Vidac Pharma Holding's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Vidac Pharma Holding Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vidac Pharma Holding PLC (STU:T9G) » Definitions » Other Current Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

Wenlock Road, 20-22, London, GBR, N1 7GU

Website

https://www.vidacpharma.com

Vidac Pharma Holding PLC is a clinical-stage biopharmaceutical company developing first-in-class oncologic and onco-dermatologic therapies. Its drug, VDA-1102, is at the clinical development stage as an ointment for patients with actinic keratosis, an early form of skin cancer, and in a separate trial for an indication of cutaneous T-cell lymphoma (CTCL). A second molecule, VDA-1275, with possible application for a wide range of solid tumors.

Vidac Pharma Holding Headlines

No Headlines